• Home
  • Study Details
By physician referral or invitation only

HPTN 106/REV UP

This study is being done by the HIV Prevention Trials Network (HPTN). It will compare the safety and acceptability of a rectal douche containing tenofovir to a pill that prevents HIV.

Age & Gender

  • 18 years ~ 99 years
  • Male

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Chatham, Durham, Orange, Wake)

Additional Study Information

Principal Investigator

Christopher Hurt
Medicine-Infectious Diseases

Study Type

Clinical or Medical
Interventional

Study Topics

Behavior
HIV/AIDS

IRB Number

24-1762

ClinicalTrials.gov

NCT06560684

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research